Everest Medicines

Investors

Announcements and Circulars

Email Alert

If you wish to receive Everest Medicines Limited information by email, please choose your options for email notification, enter your email address and information below and click "Submit".

Alert type*

Email*

First Name*

Last Name*

Company*

Profession*

Country/Region*

2021-11-11

VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON PHASE 2B STUDY OF SACITUZUMAB GOVITECAN CONDUCTED IN CHINA OF PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER MEETS PRIMARY OVERALL RESPONSE RATE ENDPOINT
2021-11-08

(1) VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE; and (2) SUPPLEMENTAL INFORMATION IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2020
2021-11-05

NEXT DAY DISCLOSURE RETURN
2021-11-03

NEXT DAY DISCLOSURE RETURN
2021-11-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED OCTOBER 30, 2021
2021-11-02

NEXT DAY DISCLOSURE RETURN
2021-11-01

NEXT DAY DISCLOSURE RETURN
2021-10-30

NEXT DAY DISCLOSURE RETURN
2021-10-28

NEXT DAY DISCLOSURE RETURN
2021-10-27

NEXT DAY DISCLOSURE RETURN